Should You Buy Limoneira Co (LMNR) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Sell
Latest Price
14.360
1 Day change
52 Week Range
23.500
Analysis Updated At
2026/01/30
LMNR is not a good buy right now for an impatient investor. The stock lacks proprietary buy signals today, near-term price-probability skews negative (next week and month), and the latest quarter showed pressured fundamentals (notably margin). While options positioning is bullish-leaning and an analyst sees longer-term upside into FY26, the current setup does not favor an immediate entry; I would avoid/exit here and look for a cleaner breakout above resistance or a deeper pullback into support before reconsidering.
Technical Analysis
Trend/Setup: Mixed-to-slightly bullish short-term but without follow-through. MACD histogram is positive (0.0669) but “positively contracting,” suggesting upside momentum is fading rather than accelerating. RSI(6) at 58.4 is neutral-to-mildly bullish (not overbought), consistent with consolidation. Moving averages are converging, typically a pre-breakout/pre-breakdown state rather than a strong trend.
Levels: Pivot 14.386 is essentially where price is hovering (~14.30–14.36). Immediate support sits at S1 14.008 then S2 13.775; a break below 14.00 would likely invite a quick move toward the high-13s. Resistance is tight above at R1 14.765 then R2 14.998—price needs a decisive close above ~14.77–15.00 to confirm a bullish continuation.
Quant pattern read-through: Similar-pattern stats imply ~+0.66% next day but -5.73% next week and -3.97% next month—net bearish bias for an impatient timeframe.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Put/call ratios are very low on both open interest (0.36) and volume (0.25), which is typically bullish (more call positioning than puts).
Activity/Liquidity: Today’s option volume is small (50 contracts; calls 40 vs puts 10) and below recent averages (today vs 30-day avg volume ~63%), so the bullish skew is not backed by heavy flow.
Volatility: 30D IV 42.79 vs historical vol 23.02 implies options are pricing elevated forward uncertainty; IV percentile ~52.6 is mid-range. Notably, near-term IV has been higher recently (5D avg ~60.8, 10D avg ~52.5), suggesting IV has been coming down from prior elevated levels.
Technical Summary
Sell
4
Buy
7
Positive Catalysts
Analyst/strategy catalyst: Lake Street initiated with Buy and sees LMNR as a “diversified asset-backed business” with multiple value creation drivers; management guidance points to FY26 as an inflection year.
Operational normalization: Q4 was pressured by late-stage Sunkist transition and restructuring/replanting; completing these could improve comparables and profitability as the transition effects fade.
Options sentiment: Low put/call ratios indicate a bullish tilt among option participants (though on modest volume).
Neutral/Negative Catalysts
with fading MACD momentum and negative week/month pattern odds; a slip below 14.00 could accelerate downside.
Financial Performance
Latest quarter: 2025/Q4.
Revenue: $42.821M, down 2.37% YoY (top-line contraction).
Net income: -$8.816M (still a loss), though improved vs prior year (reported +319% YoY improvement due to a less negative result).
EPS: -$0.49, improved YoY (+308% improvement) but remains negative.
Gross margin: -13.89% (sharp deterioration YoY), a major red flag that aligns with management commentary about transition/restructuring/replanting pressure. Overall: some loss narrowing, but the margin profile is the key weakness and undermines confidence in an immediate buy setup.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent analyst action: On 2025-12-31, Lake Street assumed coverage with a Buy rating and a $19 price target, reduced from $23.
Wall Street pro view (pros): Long-term thesis emphasizes asset-backed diversification and multiple value-creation drivers; FY26 flagged as an inflection year.
Wall Street con view (cons): Near-term profitability is pressured by operational transitions and restructuring/replanting impacts, consistent with weak Q4 margin; the lowered target signals reduced near-term optimism.
Institutional/insider/politician flows: Hedge funds neutral and insiders neutral (no notable recent trends). No recent congress trading data available.
Wall Street analysts forecast LMNR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LMNR is 19 USD with a low forecast of 19 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast LMNR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LMNR is 19 USD with a low forecast of 19 USD and a high forecast of 19 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 14.360
Low
19
Averages
19
High
19
Current: 14.360
Low
19
Averages
19
High
19
Lake Street
Buy
to
Buy
downgrade
$23 -> $19
AI Analysis
2025-12-31
Reason
Lake Street
Price Target
$23 -> $19
AI Analysis
2025-12-31
downgrade
Buy
to
Buy
Reason
Lake Street assumed coverage of Limoneira with a Buy rating and a price target of $19, down from $23. The company recently reported Q4 results that were pressured by the final stages of the Sunkist transition, restructuring actions, and avocado replanting activity, though weaker near-term profitability has a limited impact to the firm's longer-term thesis, the analyst tells investors. Management guided to FY26 as an inflection year, notes the analyst, who views Limoneira as "increasingly positioned as a diversified asset-backed business with multiple value creation drivers over the next several years."
Roth Capital
Buy
maintain
$31
2025-09-15
Reason
Roth Capital
Price Target
$31
2025-09-15
maintain
Buy
Reason
Roth Capital keeps a Buy rating and $31 on Limoneira as the company \"continues to expand its avocado acreage\". The transition to higher percentage of avocado production over lemons should lift profitability, though this will likely take another two seasons before materially impacting results, the analyst tells investors in a research note. The lemon profitability in FY26 should also improve as Limoneira merges its citrus sales and marketing into Sunkist Grower, the firm added.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LMNR
